Bayesian inference

Methods in Molecular Biology

Volumn 930, Issue , 2013, Pages 597-636

  Bois, Frederic Y ^a,b  

^a UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^b INSTITUT NATIONAL DE L ENVIRONNEMENT INDUSTRIEL ET DES RISQUES INERIS   (France)

Author keywords

Bayes rule; Bayesian statistics; Markov chain Monte Carlo simulations; Posterior distribution; Prior distribution

Indexed keywords

1,3 BUTADIENE DERIVATIVE;

ARTICLE; BAYES THEOREM; BIOLOGICAL MODEL; HUMAN; MONTE CARLO METHOD; PROBABILITY;

BAYES THEOREM; BUTADIENES; HUMANS; MARKOV CHAINS; MODELS, BIOLOGICAL; MONTE CARLO METHOD;

EID: 84870572573     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-059-5_25     Document Type: Article

References (57)

1. Albert J (2007) Bayesian computation with R. Springer, New York
2. Berger JO (1985) Statistical decision theory and Bayesian analysis, 2nd edn. Springer, New York
3. Box GEP, Tiao GC (1973) Bayesian inference in statistical analysis. Wiley, New York
4. O'Hagan A (1994) Kendall's advanced theory of statistics-volume 2B-Bayesian inference. Edward Arnold, London
5. Gelman A, Carlin JB, Stern HS, Rubin DB (2004) Bayesian data analysis, 2nd edn. Chapman & Hall, London
6. Bernardo JM, Smith AFM (1994) Bayesian theory. Wiley, New York
7. Press SJ (1989) Bayesian statistics: Principles, models, and applications. Wiley, New York
8. Whittaker J (1990) Graphical models in applied multivariate statistics. Wiley, Chichester
9. Shafer G, Pearl J (1990) Readings in uncertain reasoning. Morgan Kaufmann, San Mateo, CA
10. Gelman A (2006) Multilevel (hierarchical) modeling: What it can and cannot do. Technometrics 48:432-435
11. Chiu WA, Bois F (2007) An approximate method for population toxicokinetic analysis with aggregated data. J Agr Biol Environ Stat 12:346-363
12. Pillai G, Mentre F, Steimer JL (2005) Non-linear mixed effects modeling-from methodology and software development to driving implementation in drug development science. J Pharmacokinet Pharmacodyn 32:161-183
13. Dunson DB (2009) Bayesian nonparametric hierarchical modeling. Biom J 51:273-284
14. Gosh JK, Ramamoorthi RV (2003) Bayesian non-parametrics. Springer, New York
15. Bigelow JL, Dunson DB (2007) Bayesian adaptive regression splines for hierarchical data. Biometrics 63:724-732
16. Oppenheim J, Wehner S (2010) The uncertainty principle determines the nonlocality of quantum mechanics. Science 330:1072-1074
17. Garthwaite PH, Kadane JB, O'Hagan A (2005) Statistical methods for eliciting probability distributions. J Am Stat Assoc 100:680-700
18. Jaynes ET (2003) Probability theory: The logic of science. Cambridge University Press, Cambridge
19. Gilks WR, Richardson S, Spiegelhalter DJ (1996) Markov Chain Monte Carlo in practice. Chapman & Hall, London
20. Liu JS (2001) Monte Carlo strategies in scientific computing. Springer, New York
21. Metropolis N, Rosenbluth AW, Rosenbluth MN, Teller AH, Teller E (1953) Equation of state calculation by fast computing machines. J Chem Phys 21:1087-1092
22. Hastings WK (1970) Monte Carlo sampling methods using Markov chains and their applications. Biometrika 57:97-109
23. Gelman A, Rubin DB (1992) Inference from iterative simulation using multiple sequences (with discussion). Stat Sci 7:457-511
24. Geman S, Geman D (1984) Stochastic relaxation, Gibbs distributions, and the Bayesian restoration of images. IEEE Trans Pattern Anal Mach Intell 6:721-741
25. Doucet A, de Freitas N, Gordon N (2001) Sequential Monte Carlo methods in practice. Springer, New York
26. Andrieu C, Doucet A, Holenstein R (2010) Particle Markov chain Monte Carlo methods. J R Stat Soc B 72:269-342
27. Smith A, Gelfand A (1992) Bayesian statistics without tears: A sampling-resampling perspective. Am Stat 46:84-88
28. Rubin DB (1988) Using the SIR algorithm to simulate posterior distributions. In: Bernardo JM, De Groot MH, Lindley DV, Smith AFM (eds) Bayesian Statistics 3. Oxford University Press, Oxford, pp 395-402
29. R Development Core Team (2010) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria
30. Bois FY, Maszle D (1997) MCSim: A simulation program. J Stat Software 2(9). http:// www.jstatsoft.org/v02/i09
31. Bois FY (2009) GNU MCSim: Bayesian statistical inference for SBML-coded systems biology models. Bioinformatics 25:1453-1454
32. Hammitt JK, Shlyakhter AI (1999) The expected value of information and the probability of surprise. Risk Anal 19:135-152
33. Yokota F, Gray G, Hammitt JK, Thompson KM (2004) Tiered chemical testing: A value of information approach. Risk Anal 24:1625-1639
34. Kass RE, Raftery AE (1995) Bayes factors. J Am Stat Assoc 90:773-795
35. Green PJ (1995) Reversible jump Markov chain Monte Carlo computation and Bayesian model determination. Biometrika 82:711-732
36. Bois FY, Smith T, Gelman A, Chang H-Y, Smith A (1999) Optimal design for a study of butadiene toxicokinetics in humans. Toxicol Sci 49:213-224
37. Brochot C, Smith TJ, Bois FY (2007) Development of a physiologically based toxicokinetic model for butadiene and four major metabolites in humans: Global sensitivity analysis for experimental design issues. Chem Biol Interact 167:168-183
38. Mezzetti M, Ibrahim JG, Bois FY, Ryan LM, Ngo L, Smith TJ (2003) A Bayesian compartmental model for the evaluation of 1,3-butadiene metabolism. J R Stat Soc C 52: 291-305
39. Micallef S, Smith TJ, Bois FY (2002) Modelling of intra-individual and inter-individual variability in 1,3-butadiene metabolism. In: PAGE 11-annual meeting of the population approach group in Europe, Population Approach Group in Europe, Paris, ISSN 1871-6032
40. Ngo L, Ryan LM, Mezzetti M, Bois FY, Smith TJ (2011) Estimating metabolic rate for butadiene at steady state using a Bayesian physiologically-based pharmacokinetic model. J Environ Ecol Stat 18:131-146
41. Smith T, Bois FY, Lin Y-S, Brochot C, Micallef S, Kim D, Kelsey KT (2008) Quantifying heterogeneity in exposure-risk relationships using exhaled breath biomarkers for 1,3-butadiene exposures. J Breath Res 2: 037018 (037010 p.)
42. Smith T, Lin Y-S, Mezzetti L, Bois FY, Kelsey K, Ibrahim J (2001) Genetic and dietary factors affecting human metabolism of 1,3-butadiene. Chem Biol Interact 135-136:407-428
43. Gelman A, Bois FY, Jiang J (1996) Physiological pharmacokinetic analysis using population modeling and informative prior distributions. J Am Stat Assoc 91:1400-1412
44. Bischoff KB, Dedrick RL, Zaharko DS, Longstreth JA (1971) Methotrexate pharmacokinetics. J Pharm Sci 60:1128-1133
45. Bois FY, Zeise L, Tozer TN (1990) Precision and sensitivity analysis of pharmacokinetic models for cancer risk assessment: Tetrachloroethylene in mice, rats and humans. Toxicol Appl Pharmacol 102:300-315
46. Droz PO, Guillemin MP (1983) Human styrene exposure-V. Development of a model for biological monitoring. Int Arch Occup Environ Health 53:19-36
47. Gerlowski LE, Jain RK (1983) Physiologically based pharmacokinetic modeling: Principles and applications. J Pharm Sci 72:1103-1127
48. Reddy M, Yang RS, Andersen ME, Clewell HJ III (2005) Physiologically based pharmacokinetic modeling: Science and applications. Wiley, Hoboken, New Jersey
49. Racine-Poon A, Wakefield J (1998) Statistical methods for population pharmacokinetic modelling. Stat Methods Med Res 7:63-84
50. Lunn DJ, Best N, Thomas A, Wakefield J, Spiegelhalter D (2002) Bayesian analysis of population PK/PD models: General concepts and software. J Pharmacokinet Biopharm 29: 271-307
51. Bois F, Jamei M, Clewell HJ (2010) PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals. Toxicology 278:256-267
52. Fiserova-Bergerova V (1983) Physiological models for pulmonary administration and elimination of inert vapors and gases. In: Fiserova-Bergerova F (ed) Modeling of inhalation exposure to vapors: Uptake, distribution, and elimination. CRC Press, Boca Raton, FL, pp 73-100
53. Deurenberg P,Weststrate JA, Seidell JC (1991) Body mass index as a measure of body fatness: Age-and sex-specific prediction formulas. Br J Nutr 65:105-141
54. Filser JG, Johanson G, Kessler W, Kreuzer PE, Stei P, Baur C, Csanady GA (1993) A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: Predictions for human exposure, IARC Scientific Publication No. 127. In: Sorsa M, Pletonen K, Vainio H, Hemminki K (eds) Butadiene and styrene: Assessment of health hazards, International Agency for Research on Cancer, Lyon, France
55. Gelman A (2006) Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper). Bayesian Anal 1:515-534
56. Tanner MA,WongWH(1987) The calculation of posterior distributions by data augmentation (with discussion). J Am Stat Assoc 82:528-550
57. Amzal B, Bois FY, Parent E, Robert CP (2006) Bayesian optimal design via interacting MCMC. J Am Stat Assoc 101:773-785